Timothy August Durso - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Role: Chief Technical Officer
Signature: /s/ Michael Greco, Attorney-in-Fact
Issuer symbol: MANE
Transactions as of: 03 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Feb 2026, 19:00:50 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Durso Timothy August	Chief Technical Officer	C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN	/s/ Michael Greco, Attorney-in-Fact	05 Feb 2026	0002107508

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MANE	Common Stock	Conversion of derivative security		+1,473	+1.3%		118,190	05 Feb 2026	Direct	F1
holding	MANE	Common Stock						116,717	03 Feb 2026	By Durso Family Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MANE	Series A Convertible Preferred Stock	Conversion of derivative security		-1,473	-100%		0	05 Feb 2026	Common Stock	1,473		Direct	F1
transaction	MANE	Stock Option (Right to Buy)	Award	$0	+213,352		$0.000000	213,352	03 Feb 2026	Common Stock	213,352	$17.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (the "Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F2	These shares are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3	The option vests as to 25% of the underlying shares of Common Stock on February 3, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.